Physician

Amin Ashrafzadeh, MD

According to 2025 Medicare claims, Amin Ashrafzadeh, MD (NPI: 1326139825) practices ophthalmology in the Modesto, CA market, with the plurality of this provider's patient population coming from Stanislaus, CA. This provider's primary affiliated billing organization is MODESTO EYE CENTER INC (NPI: 1942501952; TIN: 36-4555253) and primary practice location at 95355-2807.

Ashrafzadeh's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,358 traditional Medicare patients, billed 4,693 HCPCS/CPT codes, and received $383,725 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 4,795 prescription claims across 1,213 beneficiaries totaling $186,074 in drug costs, led by Lumigan (Bimatoprost). 2023 DME data shows 15 claims. Open Payments data shows 5 records totaling $145. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,518	4,733	$524,242
2016	1,631	5,459	$565,448
2017	1,633	6,370	$559,917
2018	1,672	6,326	$540,693
2019	1,665	6,370	$563,875
2020	1,364	5,431	$423,863
2021	1,502	5,652	$511,549
2022	1,407	5,047	$435,045
2023	1,292	4,527	$387,410
2024	1,358	4,693	$383,725

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	1,161	5,862	$417,021
2016	1,219	5,593	$399,488
2017	1,215	5,563	$388,236
2018	1,298	5,909	$425,220
2019	1,315	6,128	$481,348
2020	1,250	5,833	$420,237
2021	1,390	6,526	$442,376
2022	1,520	6,723	$455,910
2023	1,205	5,065	$284,778
2024	1,213	4,795	$186,074

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	73	73	$4,591
2016	43	43	$2,762
2017	47	47	$3,270
2018	51	51	$3,485
2019	125	128	$8,685
2020	67	67	$4,689
2021	99	99	$7,841
2022	42	42	$3,105
2023	15	15	$1,009
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92004	New patient complete exam of visual system	352	352	$86
92014	Established patient complete exam of visual system	896	941	$79
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	224	377	$58
92134	Imaging of retina	561	597	$26
92133	Imaging of optic nerve	275	298	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lumigan	Bimatoprost	74	3,661	$35,509
Prednisolone Acetate	Prednisolone Acetate	638	24,110	$24,491
Latanoprost	Latanoprost	1,245	58,979	$14,632
Loteprednol Etabonate	Loteprednol Etabonate	85	4,321	$14,437
Timolol Maleate	Timolol Maleate	561	39,423	$9,538

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$145	Carl Zeiss Meditec USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Amin Ashrafzadeh, MD?

Tedicare shows public-source Medicare data for Amin Ashrafzadeh, MD (NPI 1326139825), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amin Ashrafzadeh, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Amin Ashrafzadeh, MD?

Amin Ashrafzadeh, MD is linked to MODESTO EYE CENTER INC (billing NPI 1942501952) in the available physician profile data.

Does Amin Ashrafzadeh, MD have Open Payments data?

Amin Ashrafzadeh, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.